← The Wire
INDPNasdaq
Indaptus Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1857044
Develops and tests novel immunotherapies for cancer and viral infections using a patented bacterial system
red 8-K · 90d
$405M
Market cap
$3.06
Last close
-10.3%
1D
-18.9%
5D
223K
Volume
Price · last 39 sessions+42.3%
May 4L $1.06 · H $4.75Jun 29
124
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
SC 13D/ASC 13D/AJun 26, 2026SC 13D/ASC 13D/AJun 26, 2026SC 13D/ASC 13D/AJun 26, 2026SC 13D/ASC 13D/AJun 26, 20268-KMaterial Agreement · Equity IssuanceJun 24, 20268-KExecutive ChangeJun 5, 202610-Q10-QMay 15, 20268-KResults of OperationsMay 15, 2026SC 13D/ASC 13D/AApr 29, 20268-K/AExecutive ChangeApr 24, 20268-KExecutive ChangeApr 23, 20268-KExecutive ChangeApr 3, 2026SC 13DSC 13DMar 30, 20268-KChange of Control · Executive ChangeMar 24, 2026SC 13D/ASC 13D/AMar 24, 202610-K10-KMar 17, 2026SC 13DSC 13DMar 2, 20268-KChange of Control · Security-Holder RightsFeb 27, 20268-KMaterial Agreement · Equity IssuanceFeb 12, 2026DEFA14ADEFA14AFeb 12, 2026DEF 14ADEF 14AJan 21, 20268-KExecutive ChangeJan 20, 20268-KExecutive ChangeJan 8, 20268-KExecutive ChangeJan 2, 2026SC 13D/ASC 13D/ADec 30, 2025SC 13D/ASC 13D/ADec 30, 20258-KExecutive Change · Material AgreementDec 23, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KCompany UpdateSep 4, 2025S-1/AS-1/ASep 3, 2025S-1S-1Sep 2, 2025424B5424B5Sep 2, 202510-Q10-QAug 13, 20258-KResults of OperationsAug 13, 20258-KEquity Issuance · Shareholder VoteJul 29, 20258-KCompany UpdateJul 16, 20258-KMaterial Agreement · New Debt / ObligationJul 1, 20258-KSecurity-Holder Rights · Bylaw AmendmentJun 26, 2025DEF 14ADEF 14AJun 23, 20258-KMaterial Agreement · New Debt / ObligationJun 13, 20258-KShareholder VoteJun 11, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 20258-KResults of OperationsMar 13, 202510-K10-KMar 13, 2025S-1S-1Feb 12, 20258-KMaterial Agreement · Equity IssuanceFeb 12, 20258-KDelisting NoticeJan 31, 20258-KMaterial Agreement · Equity IssuanceJan 14, 2025S-1S-1Dec 23, 20248-KMaterial Agreement · Equity IssuanceNov 22, 2024424B5424B5Nov 22, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KCompany UpdateOct 22, 2024SC 13DSC 13DOct 10, 2024S-1S-1Sep 12, 202410-Q10-QAug 12, 20248-KResults of OperationsAug 12, 20248-KMaterial Agreement · Equity IssuanceAug 8, 2024424B5424B5Aug 7, 2024424B5424B5Aug 6, 20248-KExecutive Change · Shareholder VoteJun 7, 20248-KCompany UpdateMay 22, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KCompany UpdateMar 25, 2024424B5424B5Mar 13, 202410-K10-KMar 13, 20248-KResults of OperationsMar 13, 20248-KCompany UpdateMar 4, 20248-KBylaw AmendmentJan 23, 202410-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KCompany UpdateNov 6, 2023
Similar companies
Comparable business profile · signals at a glance